- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Programmed Cell Death-Ligand 2 (PD-L2)
Total 93951 results
-
Zhongnan HospitalRecruiting
-
Instituto Nacional de Cancerologia de MexicoUnknownNon-Small Cell Lung CancerMexico
-
Gamze AkayAtaturk UniversityNot yet recruiting
-
Eastern Mediterranean UniversityNot yet recruitingHealth Literacy | School HealthCyprus
-
CureVacSyneos Health; Cromos Pharma LLCActive, not recruitingCarcinoma, Adenoid Cystic | Melanoma (Skin) | Squamous Cell Carcinoma of the Skin | Carcinoma, Squamous Cell of Head and NeckSpain, France, Austria, Germany, Russian Federation
-
University of PadovaUniversity Medical Center Groningen; Azienda Ospedaliera Universitaria Integrata... and other collaboratorsRecruitingArrhythmia | Heart Defects, Congenital | Congenital Heart Disease | Sudden Cardiac Death | Surgical Procedure, Unspecified | Diagnosis | Adult Children | Coronary Artery AnomalyItaly, Switzerland
-
University of PadovaULSS 6 Euganea; Nastrificio Victor S.p.A.CompletedAutism Spectrum DisorderItaly
-
University of PadovaEdwards Lifesciences; Azienda Ospedaliera di Padova; Ospedale San Bortolo di...Suspended
-
Incyte CorporationMerck Sharp & Dohme LLCActive, not recruitingRenal Cell Carcinoma (RCC)Canada, France, United States, Spain, United Kingdom, Italy, Taiwan, Australia, Norway, Korea, Republic of, Germany, Russian Federation, Japan, Brazil, Turkey, Ukraine, Hungary, New Zealand, Chile, Ireland
-
M.D. Anderson Cancer CenterCompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
PD Dr. Martin GlasUnknownFirst or Second Recurrence of GlioblastomaGermany
-
Merck Sharp & Dohme LLCRecruitingRenal Cell CarcinomaUnited States, Australia, Israel
-
Guangdong Association of Clinical TrialsUnknown
-
Shanghai Zhongshan HospitalRecruitingCholangiocarcinoma, Intrahepatic | PD-L1 | CTLA4China
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin's Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)Canada, United States, Brazil, Czechia, France, Italy, Poland, Russian Federation, South Africa, Turkey, Ukraine
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Primary Mediastinal B-Cell Lymphoma
-
Merck Sharp & Dohme LLCTerminated
-
TherapixelRecruiting
-
Gamze AkayAtaturk UniversityNot yet recruiting
-
University of ChicagoRecruiting
-
Shandong New Time Pharmaceutical Co., LTDNot yet recruiting
-
Second Affiliated Hospital of Soochow UniversityRecruitingAdvanced Refractory Solid TumorsChina
-
University of Colorado, BoulderNational Institute of Mental Health (NIMH); Emory University; Kaiser PermanenteCompletedDepression | Postpartum Depression | PregnancyUnited States
-
Schiffler Cancer CenterCompletedProstatic NeoplasmUnited States
-
Genentech, Inc.Completed
-
Changzhou No.2 People's HospitalNot yet recruiting
-
Merck Sharp & Dohme LLCTerminatedNeoplasmUnited States, Canada, Israel
-
CTI BioPharmaTerminatedNSCLCUnited States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
-
Jiangsu HengRui Medicine Co., Ltd.UnknownRenal Insufficiency,Type 2 DiabetesChina
-
Blokhin's Russian Cancer Research CenterRecruitingMelanomaRussian Federation
-
Mahmoud Ramadan mohamed ElkazzazNot yet recruiting
-
Duke UniversityMerck Sharp & Dohme LLC; IpsenCompletedGastroenteropancreatic Neuroendocrine TumorsUnited States
-
KU LeuvenRecruiting
-
Flint Rehabilitation Devices, LLCUniversity of Southern CaliforniaCompleted
-
China Medical University, ChinaNot yet recruitingPD-1 Antibody | Gastrointestinal Tumours | DC-Cell | NK-Cell
-
Peking Union Medical College HospitalRecruitingHepatocellular CarcinomaChina
-
Istari Oncology, Inc.Active, not recruiting
-
SpringWorks Therapeutics, Inc.Active, not recruitingPlexiform Neurofibroma | Neurofibromatosis Type 1 (NF1)United States
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Germany, Thailand, France, Belgium, China, Argentina, Greece, Turkey, Malaysia, Portugal, Hungary, Brazil, United States, India
-
PfizerCompletedHot FlashesUnited States, France, Spain, Australia, South Africa, Canada
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Sarah GoldbergMirati Therapeutics Inc.TerminatedLung Diseases | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Metastatic Lung Non-Small Cell Carcinoma | PD-L1 Gene Mutation | Pembrolizumab | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Advanced Treatment-Naïve PD-L1 | SitravatinibUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; National Cancer Institute (NCI)RecruitingRefractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy | MSI-H TumorsUnited States
-
Shanghai Zhongshan HospitalRecruitingOesophageal Squamous Cell CarcinomaChina
-
Tongji HospitalWuhan University; Sun Yat-sen University; Wuhan Union Hospital, ChinaSuspendedNon Small Cell Lung CancerChina
-
Fresenius Medical Care Deutschland GmbHWinicker Norimed GmbH; James Motta, Clinical Research Associate (CRA)CompletedRenal Failure | End Stage Renal DiseaseChile
-
Tatarstan Cancer CenterUnknownHereditary Breast CancerRussian Federation
-
Xijing HospitalRecruitingPD-1 | Locally Advanced Gastric AdenocarcinomaChina